CD4 and rheumatoid arthritis: Since autoimmune CD4+ T-lymphocytes are the main regulators of the inflammatory response in RA with a different metabolic shift from other cells in the synovial sac, the effect on specific metabolic targets characteristic of T-helpers can be a saving solution for slowing down or even stopping inflammation in the early stages of RA.